These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 32967901)

  • 21.
    Mushtaq S; Sadouki Z; Vickers A; Livermore DM; Woodford N
    Antimicrob Agents Chemother; 2020 Nov; 64(12):. PubMed ID: 32958717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activity of Cefiderocol Against
    Iregui A; Khan Z; Landman D; Quale J
    Microb Drug Resist; 2020 Jul; 26(7):722-726. PubMed ID: 32031915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In Vitro Activity of Cefiderocol, a Novel Siderophore Cephalosporin, against Gram-Negative Bacilli Isolated from Patients in Canadian Intensive Care Units.
    Golden AR; Adam HJ; Baxter M; Walkty A; Lagacé-Wiens P; Karlowsky JA; Zhanel GG
    Diagn Microbiol Infect Dis; 2020 May; 97(1):115012. PubMed ID: 32081522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multilaboratory Comparison of Omadacycline MIC Test Strip to Broth Microdilution MIC against Gram-Negative, Gram-Positive, and Fastidious Bacteria.
    Koeth LK; DiFranco-Fisher JM; Hardy DJ; Palavecino EL; Carretto E; Windau A
    J Clin Microbiol; 2022 Jan; 60(1):e0141021. PubMed ID: 34613800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of Disk Diffusion, E-Test, and Broth Microdilution Methods for Testing In Vitro Activity of Cefiderocol in
    Kolesnik-Goldmann N; Seth-Smith HMB; Haldimann K; Imkamp F; Roloff T; Zbinden R; Hobbie SN; Egli A; Mancini S
    Antibiotics (Basel); 2023 Jul; 12(7):. PubMed ID: 37508308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Performance of discs, sensititre EUMDROXF microplates and MTS gradient strips for the determination of the susceptibility of multidrug-resistant Pseudomonas aeruginosa to cefiderocol.
    Devoos L; Biguenet A; Rousselot J; Bour M; Plésiat P; Fournier D; Jeannot K
    Clin Microbiol Infect; 2023 May; 29(5):652.e1-652.e8. PubMed ID: 36587736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterisation of cefiderocol-non-susceptible Acinetobacter baumannii isolates from Taiwan.
    Yamano Y; Ishibashi N; Kuroiwa M; Takemura M; Sheng WH; Hsueh PR
    J Glob Antimicrob Resist; 2022 Mar; 28():120-124. PubMed ID: 34958997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Skipped wells and scientific error during fosfomycin agar dilution and broth microdilution lead to inconsistent minimal inhibitory concentrations and may be cause for reevaluating testing methods for
    Bixby ML; Daley EC; Collins LB; Salay JM; Bryson AL; Hirsch EB
    Microbiol Spectr; 2024 Aug; 12(8):e0420523. PubMed ID: 38940588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Performance evaluation of the UMIC® Cefiderocol to determine MIC in Gram-negative bacteria.
    Dortet L; Niccolai C; Pfennigwerth N; Frisch S; Gonzalez C; Antonelli A; Giani T; Hoenings R; Gatermann S; Rossolini GM; Naas T
    J Antimicrob Chemother; 2023 Jul; 78(7):1672-1676. PubMed ID: 37209112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colistin MIC variability by method for contemporary clinical isolates of multidrug-resistant Gram-negative bacilli.
    Hindler JA; Humphries RM
    J Clin Microbiol; 2013 Jun; 51(6):1678-84. PubMed ID: 23486719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of cefiderocol disk diffusion versus broth microdilution results when tested against
    Liu Y; Ding L; Han R; Zeng L; Li J; Guo Y; Hu F
    Microbiol Spectr; 2023 Dec; 11(6):e0535522. PubMed ID: 37855593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cefiderocol MIC quality control ranges in iron-depleted cation-adjusted Mueller-Hinton broth using a CLSI M23-A4 multi-laboratory study design.
    Huband MD; Ito A; Tsuji M; Sader HS; Fedler KA; Flamm RK
    Diagn Microbiol Infect Dis; 2017 Jun; 88(2):198-200. PubMed ID: 28410852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro activity of cefiderocol, a siderophore cephalosporin, against a recent collection of clinically relevant carbapenem-non-susceptible Gram-negative bacilli, including serine carbapenemase- and metallo-β-lactamase-producing isolates (SIDERO-WT-2014 Study).
    Kazmierczak KM; Tsuji M; Wise MG; Hackel M; Yamano Y; Echols R; Sahm DF
    Int J Antimicrob Agents; 2019 Feb; 53(2):177-184. PubMed ID: 30395986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
    Zhanel GG; Golden AR; Zelenitsky S; Wiebe K; Lawrence CK; Adam HJ; Idowu T; Domalaon R; Schweizer F; Zhanel MA; Lagacé-Wiens PRS; Walkty AJ; Noreddin A; Lynch Iii JP; Karlowsky JA
    Drugs; 2019 Feb; 79(3):271-289. PubMed ID: 30712199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combining VITEK
    Lellouche J; Schwartz D; Elmalech N; Ben Dalak MA; Temkin E; Paul M; Geffen Y; Yahav D; Eliakim-Raz N; Durante-Mangoni E; Iossa D; Bernardo M; Daikos GL; Skiada A; Pantazatou A; Antoniadou A; Mouton JW; Carmeli Y;
    Clin Microbiol Infect; 2019 Jun; 25(6):711-716. PubMed ID: 30291971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Performance of Four Fosfomycin Susceptibility Testing Methods against an International Collection of Clinical Pseudomonas aeruginosa Isolates.
    Smith EC; Brigman HV; Anderson JC; Emery CL; Bias TE; Bergen PJ; Landersdorfer CB; Hirsch EB
    J Clin Microbiol; 2020 Sep; 58(10):. PubMed ID: 32669380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imipenem-Relebactam Susceptibility Testing of Gram-Negative Bacilli by Agar Dilution, Disk Diffusion, and Gradient Strip Methods Compared with Broth Microdilution.
    Hakvoort H; Bovenkamp E; Greenwood-Quaintance KE; Schmidt-Malan SM; Mandrekar JN; Schuetz AN; Patel R
    J Clin Microbiol; 2020 Sep; 58(10):. PubMed ID: 32727832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of Fosfomycin Etest To Determine
    Karlowsky JA; Baxter MR; Golden AR; Adam HJ; Walkty A; Lagacé-Wiens PRS; Zhanel GG
    J Clin Microbiol; 2021 Nov; 59(12):e0163521. PubMed ID: 34495708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro susceptibility of Burkholderia cepacia complex isolates: Comparison of disk diffusion, Etest®, agar dilution, and broth microdilution methods.
    Fehlberg LC; Nicoletti AG; Ramos AC; Rodrigues-Costa F; de Matos AP; Girardello R; Marques EA; Gales AC
    Diagn Microbiol Infect Dis; 2016 Dec; 86(4):422-427. PubMed ID: 27638346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of a Commercial Broth Microdilution Panel for Colistin Susceptibility Testing of Clinical Isolates of Escherichia coli and Klebsiella pneumoniae.
    Mirza HC; Bıçakçıgil A; Liste Ü; Sancak B
    Clin Lab; 2021 May; 67(5):. PubMed ID: 33978373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.